HITTechnology · Software - ApplicationThe 2 Wall Street analysts covering Health In Tech, Inc. hold a median 12-month price target of $4 — +250.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 27 of 100 as at 1 Aug 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Health In Tech, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (78): Smaller than most of the companies we track.
Volatility (18): The share price moves around a lot.
The rank is the raw material. Whether the rules would actually own Health In Tech, Inc. — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on HIT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +250.9% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 20 Apr 2026 | Craig-Hallum | Initiates | Buy | $4.00 |
| 20 Apr 2026 | Craig-Hallum | Initiates | Buy | — |
| 26 June 2025 | Maxim Group | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 10% of US stocks
Cheaper than 50% of US stocks
Cheaper than 30% of US stocks
Cheaper than 12% of US stocks
Higher than 53% of US stocks
Higher than 49% of US stocks
Higher than 66% of US stocks
Higher than 22% of US stocks
Higher than 27% of US stocks
Higher than 40% of US stocks
Higher than 35% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HIT appears on the weeks it earns a place.
Health In Tech, Inc. announced it will release its second quarter 2026 financial results after market close on August 13, 2026.
Why it matters — This scheduled earnings announcement provides investors and analysts with an upcoming update on the company's financial performance for the second quarter.
The 2 Wall Street analysts covering Health In Tech, Inc. have a median 12-month price target of $4, with estimates ranging from $4 to $4.1. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 2 analysts covering Health In Tech, Inc., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Health In Tech, Inc. 27 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 1 Aug 2026, Health In Tech, Inc. ranks 27 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (78 of 100).
No one can know that. What the data says: the median 12-month target from 2 analysts implies +250.9% from the last close, and Ticker Nerd's factor model ranks Health In Tech, Inc. 27 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Health In Tech, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HIT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $4 to $4.1 over the next 12 months.
Health In Tech, Inc. returned -43.0% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Health In Tech Inc. is a company specializing in advanced technology solutions for the healthcare sector.
The most recent item we track (PRNewsWire, 3 Aug 2026): "Health In Tech to Announce Second Quarter 2026 Financial Results on August 13, 2026". Health In Tech, Inc. announced it will release its second quarter 2026 financial results after market close on August 13, 2026.
Health In Tech Inc. is a company specializing in advanced technology solutions for the healthcare sector. Its primary function is to develop innovative software platforms and digital tools designed to enhance the efficiency and effectiveness of healthcare delivery. By focusing on healthcare informatics, Health In Tech Inc. offers products that streamline data management, optimize patient care, and facilitate seamless communication within medical networks. The company's solutions are integral to supporting hospitals, clinics, and other healthcare providers in managing patient information securely and efficiently. Health In Tech Inc. plays a crucial role in the healthcare industry's digital transformation, addressing the growing demand for integrated health systems. Its products are significant in promoting interoperability and ensuring compliance with health regulations, making them indispensable for modern healthcare operations. As an influential player in the healthcare technology market, Health In Tech Inc. continues to innovate, contributing to improvements in patient outcomes and the operational success of healthcare institutions worldwide.
CEO Mr. Tim Johnson · 87 employees · United States · https://healthintech.com